Boomi World 2025: Accelerating What’s Next in AI, Integration, and the Connected Enterprise
24.4.2025 15:00:00 CEST | Business Wire | Press release
Boomi’s flagship event brings together global innovators shaping the future of AI, integration, and automation
Boomi™, the intelligent integration and automation leader, is excited to announce that Boomi World 2025 will be held May 12-15, 2025, in Dallas, Texas. This premier event will showcase the latest advancements in AI-driven integration and automation, bringing together industry leaders, innovative thinkers, and Boomi customers and partners to explore how these technologies are reshaping the future. Attendees will gain valuable insights on how to break down silos, streamline operations, and make informed, data-driven decisions through a series of keynote sessions, breakout discussions, and hands-on training opportunities.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250424969941/en/

Boomi World 2025: Accelerating What’s Next in AI, Integration, and the Connected Enterprise
Emceed by technology industry veteran and correspondent Lisa Martin, Boomi World 2025 will feature esteemed speakers, including:
- Tara Davis-Woodhall and Hunter Woodhall, Olympic Power Couple
- Paul Fipps, President, Global Industries and Strategic Growth, ServiceNow
- Charles Davis, Director, Data & Analytics, Modern Niagara
- Shari Lava, Senior Director, AI and Automation, IDC
- Shawn Rogers, CEO, BARC US
- Matt Aslett, Director of Research, Analytics and Data, ISG Software Research
- Steve Lucas, Chairman and CEO, Boomi
- Ed Macosky, Chief Product and Technology Officer, Boomi
- Leaders from Infosys, Cognizant, and more!
Boomi World 2025 will feature an unparalleled lineup of keynote speakers and breakout sessions, giving attendees exclusive access to the insights and expertise of Boomi’s executive team, product leaders, customers, and partners. During the action-packed conference, attendees will explore the transformative power of agentic AI, get a peek behind the scenes at the Boomi product roadmap, and take a deep dive into real-world applications of API management (APIM), data management, integration, and automation.
Event Highlights:
| 1. | Special Guests Tara Davis-Woodhall and Hunter Woodhall
| |
| 2. | Exclusive Announcements Attendees will be the first to hear Boomi's latest product and platform updates, including product roadmap deep dives and planned strategic initiatives. Boomi World 2025 will feature exclusive announcements that will shape the future of AI, data management, API management, and integration and automation. | |
| 3. | Pre-Conference Training and Partner Summit
Starting on May 12, Boomi World will provide optional one and two-day Pre-Conference Training and certification courses, with in-depth sessions covering the various services within the Boomi Enterprise Platform, including integration, runtime architecture, API management, AI management, and data management.
| |
| 4. | 50+ Breakout Sessions Boomi World will offer more than 50 breakout sessions focused on AI, APIM, Data Management, and Integration: | |
AI (Artificial Intelligence) sessions cover the practical implementation and possibilities for enterprise AI, discussing Boomi AI Studio capabilities and running the gamut from orchestration and agentic AI to working with robots.
| ||
| 5. | Networking Opportunities Connect with technology thought-leaders, like-minded professionals, industry experts, and Boomi partners during dedicated networking sessions. Boomi World 2025 provides a unique platform to foster collaboration, share ideas, and build valuable relationships. |
Sponsors:
A special thanks to Boomi’s partner sponsors for helping make Boomi World 2025 possible, including ServiceNow as the Pinnacle sponsor, and Cognizant and Infosys as Diamond sponsors.
Registration:
Registration is open. Secure your spot at Boomi World 2025 by visiting BoomiWorld.com.
To join the Boomi World conversation on social media, use #BoomiWorld.
Additional Resources
- Follow Boomi on X (Twitter), LinkedIn, Facebook, and YouTube
About Boomi
Boomi, the intelligent integration and automation leader, helps organizations around the world automate and streamline critical processes to achieve business outcomes faster. Harnessing advanced AI capabilities, the Boomi Enterprise Platform seamlessly connects systems and manages data flows with API management, integration, data management, and AI orchestration in one comprehensive solution. With over 23,000 customers globally and a rapidly expanding network of 800+ partners, Boomi is revolutionizing the way enterprises of all sizes achieve business agility and operational excellence. Discover more at boomi.com.
© 2025 Boomi, LP. Boomi, the ‘B’ logo, and Boomiverse are trademarks of Boomi, LP or its subsidiaries or affiliates. All rights reserved. Other names or marks may be the trademarks of their respective owners.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250424969941/en/

Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Incyte Announces Positive CHMP Opinion for Zynyz® (retifanlimab) for First-Line Treatment of Advanced Squamous Cell Carcinoma of the Anal Canal (SCAC)30.1.2026 15:29:00 CET | Press release
Pending the European Commission decision, Zynyz® (retifanlimab) in combination with carboplatin and paclitaxel (platinum-based chemotherapy) will be the first PD-1 immunotherapy treatment for patients with advanced squamous cell carcinoma of the anal canal (SCAC) in EuropeGlobally, the prevalence of SCAC is estimated at around 1 or 2 cases per 100,000 people, with a higher incidence in women than in men1,2,3The Committee for Medicinal Products for Human Use (CHMP) positive opinion is based on data from the Phase 3 POD1UM-303/InterAACT2 trial which showed patients with advanced SCAC achieved significantly improved progression-free survival with Zynyz in combination with carboplatin and paclitaxel as a first-line treatment4 Incyte (Nasdaq:INCY) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a positive opinion recommending the approval of Zynyz® (retifanlimab) in combination with carboplatin and paclitaxel (
Mediawan to Acquire The North Road Company, Creating a New Global Independent Content Platform30.1.2026 13:32:00 CET | Press release
Mediawan, the leading independent European studio led by Pierre-Antoine Capton, co-founded by Capton, Xavier Niel and Matthieu Pigasse, today announced the signing of an agreement to acquire The North Road Company (“North Road”), the preeminent independent U.S.-based studio founded by Peter Chernin. The combination creates one of the world’s largest independent studios with major creative hubs in the five continents and capabilities spanning all genres, formats and audiences. Together, Mediawan and North Road will have a stronger ability to accelerate the development of powerful IP, foster fresh creative synergies through format adaptations and co-production opportunities, and deliver ever greater value to viewers, talent and partners worldwide. The acquisition brings together two of the most dynamic independent studios in the sector with world-class creative talent, premium IP, and the scale to deliver content at the highest level. In an industry undergoing significant consolidation,
BrightSign Powers Intelligent Signage Experiences at ISE 202630.1.2026 09:00:00 CET | Press release
The Latest Players and AI Capabilities Drive Captivating, Personalized, and Interactive Signage With more industries embracing the power of visual storytelling, BrightSign, the provider of the most advanced, capable, and trusted digital media players and operating system, will showcase the latest developments in digital signage technology at ISE 2026 in Barcelona, Spain from February 3-6, 2026. BrightSign’s latest innovations come to life at booth #4S-150 through interactive real-world demos featuring retail, QSR, transportation, and corporate use cases. Visitors can test new AI-powered object detection capabilities of BrightSign players, allowing them to pick up an object and see the content on the screen respond immediately. Booth activations will be powered by BrightSign’s reliable platform including bsn.Control, BrightSignOS™, brightAuthor connected, and its global partner ecosystem. “In today’s immersive, personalized and visual world, the stakes have never been higher for powerfu
Candela Ushers in a New Era of Aesthetic Innovation at IMCAS Paris With the Launch of the Glacē™ System30.1.2026 08:30:00 CET | Press release
Iconic Vbeam® Pro and Matrix™ Systems showcased ahead of broader commercial availability Candela, a global leader in energy-based aesthetic technologies, today announced the European launch of the Glacē™ System, a facial treatment platform that signals a bold new chapter for the company and the future of aesthetic medicine. In addition to the launch of the Glacē System, Candela will also showcase its Matrix system for radiofrequency-based skin renewal and its iconic Vbeam® Pro vascular treatment platform at IMCAS 2026. Both Matrix and VBeam Pro platforms are currently available in select EMEA markets and are expected to be comprehensively launched shortly, further strengthening Candela’s leadership in the energy-based device market. Unveiled at the IMCAS World Congress 2026, these launches underscore Candela’s continued commitment to delivering innovative, science-backed treatment solutions for high-demand patient needs. Candela leads the industry in clinical efficacy and safety, suppo
Merz Therapeutics Appoints Dan Staner as President, Region Europe30.1.2026 08:00:00 CET | Press release
Merz Therapeutics today announced the appointment of Dan Staner as President, Region Europe, effective February 1, 2026. In this role, Dan will oversee the company’s European business and drive regional growth. Dan will report directly to Merz Therapeutics Chief Executive Officer, Stefan König, and will join the Therapeutics Executive Team. His appointment reflects the company’s continued commitment to strengthening its leadership capabilities and accelerating its growth strategy across key European markets. “Dan brings a strong track record of building and scaling biopharmaceutical businesses across Europe,” said Stefan König, CEO of Merz Therapeutics. “His deep commercial, strategic, and regional leadership experience will be instrumental in advancing our growth ambitions, expanding patient access to our therapies, and further strengthening our presence in Europe. We are very pleased to welcome Dan to Merz Therapeutics.” Throughout his career, Dan has held senior leadership roles i
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom